SEC Form 4 · accession 0001214659-15-008421

IMAX CORP · IMAX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Dec 14, 2015

Accepted (ET)

Dec 16, 2015 · 5:53 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000921582

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
common shares^F1	Dec 14, 2015	C	33,333	$28.19	A	147,026	D
common shares^F1	Dec 14, 2015	S	33,333	$37.7637	D	113,693	D
common shares^F1	Dec 15, 2015	C	33,333	$28.19	A	147,026	D
common shares^F1	Dec 15, 2015	S	33,333	$39.0333	D	113,693	D
common shares^F1	Dec 16, 2015	C	33,334	$28.19	A	147,027	D
common shares^F1	Dec 16, 2015	S	33,334	$39.5755	D	113,693	D
common shares (opening balance)	holding	—	—		—	98,593	D
common shares (opening balance)	holding	—	—		—	7,550	I	by "Pamela Gelfond Trust"
common shares (opening balance)	holding	—	—		—	7,550	I	by "Claudia Gelfond Trust"

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
stock options (to buy)^F1,F2	$28.19	Dec 14, 2015	C	33,333	D	May 1, 2011	Dec 31, 2020	common shares	33,333	749,995	D
stock options (to buy)^F1,F2,F3	$28.19	Dec 15, 2015	C	33,333	D	—	Dec 31, 2020	common shares	33,333	716,662	D
stock options (to buy)^F1,F2	$28.19	Dec 16, 2015	C	33,334	D	Sep 1, 2011	Dec 31, 2020	common shares	33,334	683,328	D

F1Stock options were exercised and common shares sold pursuant to Rule 10b5-1 Sales Plan adopted on August 14, 2015. Mr. Gelfond's 10b5-1 Sales Plan is scheduled to terminate on September 16, 2016.
F2This represents the remaining balance of the options granted on the issue date, December 31, 2011, following this transaction. Mr. Gelfond's aggregate remaining outstanding option, RSU and long share balances following all transactions will be 1,577,648; 59,978 and 113,693 respectively.
F3The options became exercisable in 2 installments: 29,995 became exercisable on May 1, 2011 and 3,338 became exercisable on September 1, 2011.